Australian Availability of Blarcamesine Now Assured
HL Pharma is pleased to announce we are working with Anavex Life Sciences Corporation to facilitate the ongoing supply of medication to patients post clinical trial completions for Rett Syndrome and the treatment of Alzheimer’s Disease.
There have been concerns that blarcamesine would not be available in Australia after the formal trials end there. Supposedly, trial participants got the drug from those conducting the trial, and they got it from Anavex Life Sciences Corp.
Now, with this announcement, an Australian firm specializing in the "sourcing and the supply of unregistered pharmaceuticals and clinical trial supplies for a range of healthcare professionals" will be adequately supplying the drug in Australia. https://hlpharma.com.au/
Another of the continuing sequence of Anavex dots, which when connected point directly to a substantial, successful future.
Glad I got some additional AVXL shares yesterday — at the low of the day, even.